BioCentury
ARTICLE | Clinical News

Advitech preclinical data

October 10, 2005 7:00 AM UTC

In 2 in vivo models of acute and chronic inflammatory bowel disease (IBD), XP-828L significantly improved several clinical parameters associated with inflammatory colitis. XP-828L is a protein extract...